Reem M. Alsulaiman
Jeddah, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Broadly Protective Antibody-Like Vaccines Against Highly Pathogenic Coronaviruses.
Journal: Journal of medical virology
Published: October 06, 2025
Intranasal CD40-targeted recombinant MERS-CoV S1 protein is superior to intramuscular immunization in eliciting systemic and mucosal immune responses in mice.
Journal: Vaccine
Published: July 14, 2025
Mucosal SARS-CoV-2 S1 adenovirus-based vaccine elicits robust systemic and mucosal immunity and protects against disease in animals.
Journal: mBio
Published: December 04, 2024
ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaks.
Journal: Antibody therapeutics
Published: October 12, 2023
A Modified Recombinant DNA-Based SARS-CoV-2 Vaccine Expressing Stabilized Uncleavable Spike Protein Elicits Humoral and Cellular Immunity against Various SARS-CoV-2 Variants of Concern.
Journal: Transboundary and emerging diseases
Published: April 13, 2023
Construction of VSVΔ51M oncolytic virus expressing human interleukin-12.
Journal: Frontiers in molecular biosciences
Published: March 21, 2023
Amplifying Lateral Flow Assay Signals for Rapid Detection of COVID-19 Specific Antibodies.
Journal: Global challenges (Hoboken, NJ)
Published: January 31, 2022
DNA Based Vaccine Expressing SARS-CoV-2 Spike-CD40L Fusion Protein Confers Protection Against Challenge in a Syrian Hamster Model.
Journal: Frontiers in immunology
Published: September 29, 2021
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients.
Journal: Viruses
Published: October 31, 2020
SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.
Journal: Scientific reports
Published: June 19, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026